Skip to content
Study details
Enrolling now

The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors

University of California, Davis
NCT IDNCT05967533ClinicalTrials.gov data as of Apr 2026
Phase

Phase 1

Target enrollment

100

Study length

about 3.6 years

Ages

18+

Locations

1 site in CA

What this study is about

This trial is testing the immune effects of fermented wheat germ in patients with advanced solid tumor cancers who are being treated with standard checkpoint inhibitors. This treatment is a nutritional supplement that some claim to support cancer patients during treatment, but there's currently no evidence it has therapeutic benefits as a supplement. The goal is to see if adding fermented wheat germ to standard treatment can be helpful for these patients.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Take Fermented Wheat Germ Extract

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Secondary: Adverse events, Immunologic effects of FWG (Immune Correlates): assay of T cell proliferation, cytokine production and cytotoxic lymphocyte (CTL) activity

Body systems

Oncology